Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2004 | 03-2004 | 12-2003 | 09-2003 | 06-2003 | |
| Sales | 25,783 | 27,628 | 13,613 | 9,325 | 21,001 |
| Gross Profit | 25,783 | 27,628 | 13,613 | 9,325 | 21,001 |
| Operating Expenses | 39,459 | 41,097 | 80,716 | 28,775 | 65,565 |
| Operating Income | -13,676 | -13,469 | -67,103 | -19,450 | -44,564 |
| Interest Expense | 1,351 | 1,385 | 2,424 | 3,705 | 1,755 |
| Other Income | 2,583 | 2,284 | -3,320 | 4,291 | 4,188 |
| Pre-tax Income | -12,444 | -12,570 | -72,847 | -18,864 | -42,131 |
| Income Tax | 8 | 48 | 12 | 11 | 18 |
| Net Income Continuous | -12,452 | -12,618 | -72,859 | -18,875 | -42,149 |
| Net Income | $-12,452 | $-12,618 | $-72,859 | $-18,875 | $-42,149 |
| EPS Basic Total Ops | -0.13 | -0.13 | -0.80 | -0.20 | -0.45 |
| EPS Basic Continuous Ops | -0.13 | -0.13 | -0.80 | -0.20 | -0.45 |
| EPS Diluted Total Ops | -0.13 | -0.13 | -0.80 | -0.20 | -0.45 |
| EPS Diluted Continuous Ops | -0.13 | -0.13 | -0.80 | -0.20 | -0.45 |
| EBITDA(a) | $-9,870 | $-9,966 | $-63,506 | $-16,386 | $-42,333 |